Superficial Vein Products
Superficial Vein Products
The VenaSeal™ closure system offers relief for patients suffering from venous reflux disease by using a proprietary and proven medical adhesive to permanently close the vein.
The VenaSeal closure system (VenaSeal system) is indicated for use in the permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein (GSV), through endovascular embolization with coaptation. The VenaSeal system is intended for use in adults with clinically symptomatic venous reflux as diagnosed by duplex ultrasound (DUS).
With no need for heat, the VenaSeal procedure delivers a comfortable patient experience1,2* and immediate vein closure,1,2 with the results you have come to expect.
The VenaSeal closure system provides immediate vein closure, delivering consistent and reproducible results for your patients without the need for post-procedure compression stockings.1,2,**
The proprietary catheter is highly visible under ultrasound, allowing precise delivery of the adhesive. The dispensing gun precisely controls the amount of adhesive, delivering 0.10 cc aliquots with each trigger pull.
The viscosity of the adhesive is specifically designed to minimize migration and embolization.
Upon contact with blood, the adhesive begins to bond with the intima and compression is applied to close the vein. The adhesive was designed to remain permanently in the diseased vein and is encapsulated by chronic fibrosis.3
The adhesive is designed to be soft and flexible, and less likely to be felt by the patient.
The VenaSeal closure system procedure offers:
The VenaSeal closure system procedure eliminates:1,2
Instructions for use can be found in the product labeling at http://manuals.medtronic.com.
Some patients may benefit from the use of compression stockings post-procedure.
Proebstle, T.M. The European Multicenter Study on Cyanoacrylate Embolization of Refluxing Great Saphenous Veins without Tumescent Anesthesia and without Compression Therapy. Results presented at: Charing Cross; 2016; London, UK.
Almeida, J.I., Jacier, J.J., Mackay, E.G., Bautista, C., Cher, D.J. and Proebstle, T.M. Thirty-Sixth Month Follow-up of First-in-human Use of Cyanoacrylate Adhesive for Treatment of Saphenous Vein Incompetence. J Vasc Surg: Venous and Lymphatic Disorders. 2017. Published Online: 2 June 2017.
Morrison, N. VenaSeal Closure System vs. Radiofrequency Ablation for Incompetent Great Saphenous Veins (VeClose). 36-Month Results presented at: IVC; April 20,2017; Miami, FL.
Gibson, K., and Ferris, B. Cyanoacrylate Closure of Incompetent Great, Small and Accessory Saphenous Veins Without the Use of Post-procedure Compression: Initial Outcomes of a Post-market Evaluation of the VenaSeal System (the WAVES Study). Vascular (2016) May 20, Epub 2016 May, 1708538116651014.
Morrison, N., Gibson, K., McEnroe, S., Goldman, M., King, T., Weiss, R., Cher, D., Jones, A. Randomized Trial Comparing Cyanoacrylate Embolization and Radiofrequency Ablation for Incompetent Great Saphenous Veins (VeClose). J Vasc Surg. 2015;61(4):985–994.
Morrison, N., et al. VeClose Trial 12-month Outcomes of Cyanoacrylate Closure Versus Radiofrequency Ablation for Incompetent Great Saphenous Veins. J Vasc Surg. http://dx.doi.org/10.1016/j.jvsv.2016.12.005.